MMPI vulnerability indicators for schizophrenia and attention deficit disorder:
UCLA family study of biological parents of offspring with childhood-onset schizophrenia or ADHD Minnesota Multiphasic Personality Inventory (MMPI) scores were examined for 50 parents of children with an onset of schizophrenia prior to 14 years of age, 153 parents of children with attention deficit hyperactivity disorder (ADHD), and 168 parents of community comparison children. The […]
DSM III Schizophreniform Disorder
Using five methods of validation the authors evaluated six patients satisfying DSM-III criteria for schizophreniform disorder. These patients did not differ importantly from patients with affective disorders but differed markedly from schizophrenic patients in past psychiatric history, family history, acute treatment response, short- term course, and dexamethasone suppression test results. The findings suggest that schizophreniform […]
Dialysis for Schizophrenia: Review of Clinical Trials and Implications for Further Research
At least 67 schizophrenic patients have undergone dialysis for renal failure, without improvement in schizophrenic symptoms. Ninety-two nonuremic schizophrenic patients have received dialysis in nonblind studies; 22 improved, 21 improved partially, 47 showed no change, and 2 became worse. The authors point out factors other than dialysis that may affect outcome, including family response and […]
Anxiety Disorders
Do you have an anxiety disorder? Anxiety is the most common psychological condition in the U.S., even more so than depression or substance abuse. It affects over 40 million adults, almost 20% of the population. Most people have experienced anxiety at some point in their lives. There are several anxiety disorders that require the clinical […]
The International Society for Bipolar Disorders
This lecture reviews the use of Antidepressants in Bipolar Disorder. How to prescribe them, the dangers, and other recommendations. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders November 2014 David L. Fogelson, M.D. Clinical Professor of Psychiatry David Geffen School of Medicine at UCLA And The Semel […]
What is new in DSM-5
What is new in DSM-5 for Schizophrenia Spectrum & other Psychotic Disorders; Bipolar & Related Disorders; Depressive Disorders; and Personality Disorders? Going over what is new in the DSM-5 for Schizophrenia Spectrum & other Psychotic Disorders; Bipolar & Related Disorders; Depressive Disorders; and Personality Disorders. Disclosures Grant Support from Genentech The grant is a naturalistic […]